Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-16-625012
Filing Date
2016-06-17
Accepted
2016-06-17 16:30:57
Documents
9
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A d199753d10ka.htm 10-K/A 76651
2 EX-10.34 d199753dex1034.htm EX-10.34 270843
3 EX-10.35 d199753dex1035.htm EX-10.35 319351
4 EX-31.1 d199753dex311.htm EX-31.1 2719
5 EX-31.2 d199753dex312.htm EX-31.2 2671
6 GRAPHIC g199753g47y20.jpg GRAPHIC 30507
7 GRAPHIC g199753g56b35.jpg GRAPHIC 14283
8 GRAPHIC g199753g67h27.jpg GRAPHIC 61401
9 GRAPHIC g199753g71u20.jpg GRAPHIC 7666
  Complete submission text file 0001193125-16-625012.txt   830570
Mailing Address 6320 QUADRANGLE DRIVE SUITE 360 CHAPEL HILL NC 27517-8149
Business Address 6320 QUADRANGLE DRIVE SUITE 360 CHAPEL HILL NC 27517-8149 919-576-2306
CEMPRA, INC. (Filer) CIK: 0001461993 (see all company filings)

EIN.: 262644445 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-35405 | Film No.: 161720476
SIC: 2834 Pharmaceutical Preparations